300254 Shanxi C&Y Pharmaceutical Group
- 7.76
- 0.000.00%
Shanxi C&Y Pharmaceutical Group News
Qianyuan Pharmaceutical: Announcement on the signing of the “Supplementary Agreement to the Asset Sale Agreement”
Qianyuan Pharmaceutical: Announcement on the signing of the “Asset Sale Agreement”
Qianyuan Pharmaceutical: Announcement on the Signing of the “Asset Sale Framework Agreement”
Qianyuan Pharmaceutical: 1-1 Application Instructions (Application Draft)
Qianyuan Pharmaceutical: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Qianyuan Pharmaceutical: 4-1 Legal Opinion (Application Draft)
Qianyuan Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)
Qianyuan Pharmaceutical: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Qianyuan Pharmaceutical: 1-1 Application Instructions (Application Draft)
Qianyuan Pharmaceutical: Announcement on the transfer of part of the shares of Sichuan Qianyuan Traditional Chinese Medicine Tablets Co., Ltd.
Qianyuan Pharmaceutical: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Qianyuan Pharmaceutical: 3-3 Listing Sponsorship Letter (Application Draft)
Qianyuan Pharmaceutical: 1-1 Application Instructions (Application Draft)
Qianyuan Pharmaceutical: 4-1 Legal Opinion (Application Draft)
Qianyuan Pharmaceutical: 3-1 Securities Issuance Sponsorship Letter (Declaration Draft)
Qianyuan Pharmaceutical: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Qianyuan Pharmaceutical: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Qianyuan Pharmaceutical: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Qianyuan Pharmaceutical: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Qianyuan Pharmaceutical: Progress Announcement on Using Idle Own Funds to Purchase Wealth Management Products
Analysis
Price Target
No Data
